NYSE Equity Snapshot

HLN Weekly Equity Report

Haleon plc

Latest Close 9.13 USD 12 Jun 2026
1W Return 0.1% latest completed week
4W Return 1.9% short-term follow-through
12W Return -8.1% quarterly tape
Trend Breadth 30.8% 16 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
Company Brief

What the company does

Haleon plc (HLN) is a leading global consumer health company, formed as a spin-off from GlaxoSmithKline, that specializes in delivering innovative health solutions through its extensive portfolio of trusted brands, including Sensodyne, Panadol, and Voltaren. With a focus on key health segments such as oral care, pain relief, and dietary supplements, Haleon leverages strong brand recognition to meet the evolving needs of consumers. The company's commitment to sustainability and continuous innovation positions it strategically for long-term growth, aimed at enhancing health outcomes and delivering shareholder value through targeted investments and ongoing product development.

Snapshot

What the weekly tape is saying

HLN closed the latest completed week at 9.13 USD. The 4-week return is 1.9% and the 12-week return is -8.1%. Trend Signal is inactive, Market Dynamics is -1.07. Setup signature: Risk-first tape with a 35/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -7.0%
Volume 1.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 17 Persistence of active Trend Signal over the last year and current streak.
Momentum 47 Blend of 4-week and 12-week follow-through.
Dynamics 29 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 7 Relative leadership and short-term RS change.
Volume 56 Participation compared with the 13-week volume baseline.
Risk Control 53 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
9.82 USD
Vs Trend Line
-7.0%
Fair Value
9.08 USD
Vs Fair Value
0.6%
52W High
11.13 USD
52W Low
8.60 USD
Drawdown
-18.0%
Range Position
21.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.1%
4W 1.9%
12W -8.1%
26W -2.8%
52W -14.4%

Trend read

Active Streak
0 weeks
52W Active Weeks
16
52W Active Breadth
30.8%
Sector Scope
US Healthcare
Sector Rank
533 of 1038
Sector Percentile
48.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.07
4W MD Change
-18.4%
Relative Strength
-14.81
4W RS Change
21.5%
Expectation
Positive
Probability
59.94%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
55.6M
13W Average
41.7M
52W Average
45.4M
Vs 13W
1.3x
Vs 52W
1.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
1.8%
52W Volatility
2.7%
Upside Weeks
24
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
2.0% / -2.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NYSE
Country
US
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Market Cap
40.1B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 9.13 USD 0.1% 9.82 USD 9.08 USD -1.07 -14.81 55.6M Off
5 Jun 2026 9.12 USD 0.7% 9.83 USD 9.07 USD -1.14 -15.07 42.7M Off
29 May 2026 9.06 USD -2.5% 9.84 USD 9.06 USD -1.03 -18.39 28.5M Off
22 May 2026 9.29 USD 3.7% 9.84 USD 9.05 USD -0.95 -15.88 37.3M Off
15 May 2026 8.96 USD -1.6% 9.83 USD 9.04 USD -0.90 -18.86 45.4M Off
8 May 2026 9.11 USD -2.9% 9.85 USD 9.04 USD -0.82 -17.95 69.3M Off
1 May 2026 9.38 USD -2.1% 9.84 USD 9.03 USD -0.88 -14.25 39.9M Off
24 Apr 2026 9.58 USD -1.7% 9.82 USD 9.03 USD -0.83 -12.23 31.5M Off
17 Apr 2026 9.75 USD -0.9% 9.79 USD 9.02 USD -0.70 -10.75 37.4M Off
10 Apr 2026 9.84 USD 0.4% 9.77 USD 9.01 USD -0.57 -6.48 27.7M On
2 Apr 2026 9.80 USD 1.3% 9.76 USD 9.00 USD -0.31 -3.98 36.4M On
27 Mar 2026 9.67 USD -2.7% 9.76 USD 8.99 USD -0.05 -2.50 50.7M On
20 Mar 2026 9.94 USD 0.4% 9.76 USD 8.98 USD 0.49 -2.39 40.4M On
13 Mar 2026 9.90 USD -2.4% 9.75 USD 8.97 USD 0.94 -4.83 46.2M On